| Inhibition of serotonin receptor type 1 in acute myeloid leukemia impairs leukemia stem cell functionality: a promising novel therapeutic target A Etxabe, MC Lara-Castillo, JM Cornet-Masana, A Banus-Mulet, ... Leukemia 31 (11), 2288-2302, 2017 | 27 | 2017 |
| Repositioning of bromocriptine for treatment of acute myeloid leukemia MC Lara-Castillo, JM Cornet-Masana, A Etxabe, A Banús-Mulet, ... Journal of translational medicine 14, 1-10, 2016 | 26 | 2016 |
| Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells JM Cornet-Masana, A Banús-Mulet, JM Carbó, MÁ Torrente, F Guijarro, ... EBioMedicine 47, 221-234, 2019 | 22 | 2019 |
| Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells JM Cornet-Masana, D Moreno-Martínez, MC Lara-Castillo, M Nomdedeu, ... Oncotarget 7 (17), 23239, 2016 | 17 | 2016 |
| Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML A Banús-Mulet, A Etxabe, JM Cornet-Masana, MÁ Torrente, ... Scientific Reports 8 (1), 13883, 2018 | 11 | 2018 |
| Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma M Nomdedeu, MC Lara-Castillo, A Etxabe, JM Cornet-Masana, ... Cancer cell international 15, 1-7, 2015 | 10 | 2015 |
| Lysosome-mediated chemoresistance in acute myeloid leukemia L Cuesta-Casanovas, J Delgado-Martínez, JM Cornet-Masana, JM Carbó, ... Cancer Drug Resistance 5 (1), 233, 2022 | 7 | 2022 |
| Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome F Guijarro, M López-Guerra, J Morata, A Bataller, S Paz, ... Blood Advances 7 (19), 5799-5811, 2023 | 5 | 2023 |
| A novel family of lysosomotropic tetracyclic compounds for treating leukemia JM Carbó, JM Cornet-Masana, L Cuesta-Casanovas, J Delgado-Martínez, ... Cancers 15 (6), 1912, 2023 | 3 | 2023 |
| New therapeutic approaches for acute myeloid leukemia RM Risueño, L Cuesta-Casanovas, JM Carbó, JM Cornet-Masana EMJ 6 (2), 82-89, 2021 | 2 | 2021 |
| Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia L Cuesta-Casanovas, J Delgado-Martínez, JM Cornet-Masana, JM Carbó, ... Cancer Cell International 23 (1), 97, 2023 | 1 | 2023 |
| P397: PROLACTIN RECEPTOR CONFERS CHEMORESISTANCE DUE TO SENESCENCE ENTRANCE IN ACUTE MYELOID LEUKEMIA L Cuesta-Casanovas, JM Cornet-Masana, JM Carbó, J Delgado-Martínez, ... HemaSphere 6, 297-298, 2022 | | 2022 |
| P425: ROLE OF LYSOSOMAL-ASSOCIATED GENE LAPMT4B IN LEUKEMIA J Delgado-Martínez, JM Cornet-Masana, L Cuesta-Casanovas, JM Carbó, ... HemaSphere 6, 325-326, 2022 | | 2022 |
| Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity JM Cornet‐Masana, A Banús‐Mulet, L Cuesta‐Casanovas, JM Carbó, ... Journal of Cellular and Molecular Medicine 24 (22), 13536-13541, 2020 | | 2020 |
| PF163 TARGETING LYSOSOMES AS A POTENTIAL THERAPEUTIC APPROACH FOR T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA AB Mulet, JM Cornet-Masana, JM Carbó, L Cuesta-Casanovas, F Guijarro, ... HemaSphere 3 (S1), 33-34, 2019 | | 2019 |
| Reposicionament d’antihistamínics lisosomòtrops per a neoplàsies hematològiques JM Cornet Masana Universitat de Barcelona, 2018 | | 2018 |
| Biological and Therapeutic Implications of Cancer Stem Cells RM Risueño, A Etxabe, JM Cornet-Masana Frontiers in Stem Cell and Regenerative Medicine Research 2, 63, 2016 | | 2016 |
| Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma M Nomdedeu i Fàbrega, MC Lara Castillo, A Etxabe, JM Cornet Masana, ... Cancer Cell International, 2015, vol. 15, p. 122, 2015 | | 2015 |
